We are an Australian MedTech company with a vision to create a world with zero preventable deaths due to the lack of timely molecular-level data.
We are developing a Continuous Molecular Monitoring platform technology that can provide clinicians with real-time and continuous data for multiple targets.
To date, we have raised $10 million, won an award for Technology Platform Solution of the Year at the National iawards, and been a Top 5 finalist in the medTech Innovator program. Our team of 15 are currently working towards our first-in-human clinical trials.
Join us on our journey to revolutionise precision medicine and put an end to preventable tragedies.
We are developing a Continuous Molecular Monitoring platform technology that can provide clinicians with real-time and continuous data for multiple targets.
To date, we have raised $10 million, won an award for Technology Platform Solution of the Year at the National iawards, and been a Top 5 finalist in the medTech Innovator program. Our team of 15 are currently working towards our first-in-human clinical trials.
Join us on our journey to revolutionise precision medicine and put an end to preventable tragedies.
Location: Australia, Victoria, Melbourne
Total raised: $20.5M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | MedTech Ac... | medtechact... |
| 19.05.2022 | VU Venture... | vuventurep... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 09.09.2022 | Series B | $14M | VU Venture... |
Mentions in press and media 10
| Date | Title | Description |
| 07.09.2026 | Prof Kevin Plaxco joins Nutromics as Chief Scientific Officer, bolstering expansion efforts for the DNA-based sensing platform | MELBOURNE, Australia, Sept. 7, 2026 /PRNewswire/ -- Nutromics, a Melbourne-based startup leading the frontier of DNA-based sensing, has announced the appointment of Professor Kevin W. Plaxco as Chief Scientific Officer (CSO). The company is... |
| 09.09.2022 | Medtech Nutromics lands $20.5 million for wearable diagnostic device | Melbourne medtech startup Nutromics has raised US$14 million (A$20.5m) for its wearable diagnostic platform as it looks to ramp up its expansion in Australia and the US. The round was led by the venture arm of US medical device company Dexc... |
| 09.09.2022 | Lab-on-a-patch maker Nutromics scores $14M from Dexcom Ventures, others | Credit: Nutromics |
| 08.09.2022 | Nutromics raises US$14 million for its ground-breaking wearable diagnostic platform | MELBOURNE, Australia and SAN DIEGO, Sept. 8, 2022 /PRNewswire/ -- Global MedTech start-up Nutromics has raised an additional US $14 million for its wearable diagnostic platform. This transformative funding is key to Nutromics' continued exp... |
| 08.09.2022 | Nutromics Raises US$14M in Funding | Nutromics patch Nutromics, a Brunswick, Australia-based MedTech startup, raised US$14M in funding. The round was led by Dexcom Ventures, VU Venture Partners, and Artesian Investments. This latest round of funding will support an expansion o... |
| 27.08.2021 | Australian medtech startup Nutromics bags $4M in pre-market funding for continuous molecular monitoring device | Credit: Nutromics |
| - | Nutromics | “Nutromics – Solving some of the biggest healthcare challenges” |
| - | Nutromics | “Nutromics' vision is to create a world with zero preventable deaths due to the lack of timely molecular patient data.” |
| - | Wearable Diagnostic Platform Company Nutromics Raises $14 Million | Nutromics recently announced that it raised $14 million. These are the details. Nutromics recently announced that it raised $14 million. |
| - | Nutromics | “Nutromics vision is a world with zero preventable deaths due to a lack of continuous diagnostic monitoring.Explore Nutromics' innovative diagnostic solutions. Offering Continuous Diagnostic Monitoring through advanced DNA-based sensors, ou... |